Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-23 Sale | 2024-01-24 4:20 pm | Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks | 15,853 | $7.6415 | $121,141 | 292,850 (Indirect Direct) | View |
| 2024-01-23 Sale | 2024-01-24 4:18 pm | Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer | 6,609 | $7.6443 | $50,521 | 62,991 (Direct) | View |
| 2023-11-07 Purchase | 2023-11-09 5:02 pm | Aura Biosciences Inc. | AURA | Johnson David Michael Director | 199,601 | $7.1893 | $1,434,987 | 350,339 (Indirect Direct) | View |
| 2023-11-09 Purchase | 2023-11-09 4:35 pm | Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 1,560,000 | $9 | $14,040,000 | 6,922,870 (Indirect) | View |
| 2023-11-06 Sale | 2023-11-07 6:19 pm | Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks | 7,449 | $12.03 | $89,611 | 669,866 (Indirect Direct) | View |
| 2023-11-06 Sale | 2023-11-07 6:09 pm | Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer | 3,900 | $12.07 | $47,054 | 155,357 (Direct) | View |
| 2023-10-30 Sale | 2023-11-01 6:24 pm | Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer | 3,385 | $6.8215 | $23,091 | 69,600 (Direct) | View |
| 2023-10-30 Sale | 2023-11-01 6:21 pm | Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks | 9,586 | $6.8306 | $65,478 | 312,352 (Indirect Direct) | View |
| 2023-10-03 Purchase | 2023-10-05 7:56 pm | Aura Biosciences Inc. | AURA | Johnson David Michael Director | 20,066 | $8.3811 | $168,175 | 225,738 (Indirect Direct) | View |
| 2023-01-05 Purchase | 2023-01-09 5:55 pm | Aura Biosciences Inc. | AURA | Johnson David Michael Director | 2,000 | $10.41 | $20,811 | 18,000 (Indirect) | View |
| 2022-12-28 Purchase | 2022-12-30 7:01 pm | Aura Biosciences Inc. | AURA | Johnson David Michael Director | 4,000 | $9.75 | $39,000 | 17,000 (Indirect) | View |
| 2022-12-01 Purchase | 2022-12-15 6:15 pm | Aura Biosciences Inc. | AURA | Johnson David Michael Director | 10,000 | $12.37 | $123,700 | 15,000 (Indirect) | View |
| 2022-12-05 Purchase | 2022-12-07 4:30 pm | Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 1,250,000 | $12 | $15,000,000 | 5,362,870 (Indirect) | View |
| 2022-10-31 Sale | 2022-11-02 8:39 pm | Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer | 2,015 | $12.45 | $25,090 | 24,235 (Direct) | View |
| 2022-10-31 Sale | 2022-11-02 8:38 pm | Aura Biosciences Inc. | AURA | Rich Cadmus See Remarks | 1,672 | $12.45 | $20,813 | 24,578 (Direct) | View |
| 2022-10-31 Sale | 2022-11-02 8:37 pm | Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks | 5,706 | $12.46 | $71,082 | 200,063 (Indirect Direct) | View |
| 2022-10-31 Sale | 2022-11-02 8:36 pm | Aura Biosciences Inc. | AURA | De Rosch Mark Chief Operating Officer | 1,115 | $12.46 | $13,890 | 16,385 (Direct) | View |
| 2022-06-10 Purchase | 2022-06-14 9:29 pm | Aura Biosciences Inc. | AURA | Johnson David Michael Director | 50,000 | $14.33 | $716,300 | 40,000 (Indirect Direct) | View |
| 2021-11-02 Purchase | 2021-11-04 5:00 pm | Aura Biosciences Inc. | AURA | Medicxi Ventures Management (Jersey) Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi Growth I GP Ltd 10% Owner | 710,000 | $14 | $9,940,000 | 70,540 (Indirect) | View |
| 2021-11-02 Purchase | 2021-11-04 4:44 pm | Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 1,785,000 | $14 | $24,990,000 | 4,112,870 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-02 Option Award | 2024-04-04 4:10 pm | N/A 2034-04-01 | Aura Biosciences Inc. | AURA | Kilroy Conor General Counsel and Secretary | 240,000 | $0 | 240,000 (Direct) | View |
Ownership | 2024-03-25 4:01 pm | N/A N/A | Aura Biosciences Inc. | AURA | Plavsic Mark Chief Technology Officer | 0 | $0 | 308,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:01 pm | N/A 2034-01-31 | Aura Biosciences Inc. | AURA | Hopkins Janet Jill Chief Medical Officer | 70,000 | $0 | 205,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:01 pm | N/A 2034-01-31 | Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer | 175,000 | $0 | 237,991 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:01 pm | N/A 2034-01-31 | Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks | 400,000 | $0 | 692,850 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-07 6:19 pm | N/A N/A | Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks | 3,800 | $2.74 | 669,866 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-07 6:19 pm | N/A 2028-02-21 | Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks | 3,800 | $0 | 669,866 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-07 6:09 pm | N/A N/A | Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer | 3,900 | $2.74 | 155,357 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-07 6:09 pm | N/A 2028-10-03 | Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer | 3,900 | $0 | 155,357 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-03 5:04 pm | N/A 2033-10-31 | Aura Biosciences Inc. | AURA | Hopkins Janet Jill Chief Medical Officer | 335,000 | $0 | 335,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:57 pm | N/A 2033-06-07 | Aura Biosciences Inc. | AURA | Mattessich Antony C. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:56 pm | N/A 2033-06-07 | Aura Biosciences Inc. | AURA | Johnson David Michael Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:56 pm | N/A 2033-06-07 | Aura Biosciences Inc. | AURA | PAREKH RAJESH B Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:54 pm | N/A 2033-06-07 | Aura Biosciences Inc. | AURA | Srivastava Sapna Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 6:38 pm | N/A 2033-01-18 | Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer | 123,750 | $0 | 147,985 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 6:36 pm | N/A 2033-01-18 | Aura Biosciences Inc. | AURA | De Rosch Mark Chief Operating Officer | 107,250 | $0 | 123,635 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 6:35 pm | N/A 2033-01-18 | Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks | 309,375 | $0 | 509,438 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 6:34 pm | N/A 2033-01-18 | Aura Biosciences Inc. | AURA | Rich Cadmus See Remarks | 86,625 | $0 | 111,203 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:09 pm | N/A 2032-06-15 | Aura Biosciences Inc. | AURA | PAREKH RAJESH B Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:07 pm | N/A 2032-06-15 | Aura Biosciences Inc. | AURA | Johnson David Michael Director | 16,000 | $0 | 205,672 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:07 pm | N/A 2032-06-15 | Aura Biosciences Inc. | AURA | Srivastava Sapna Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:06 pm | N/A 2032-06-15 | Aura Biosciences Inc. | AURA | Mattessich Antony C. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2021-11-02 Conversion | 2021-11-04 5:00 pm | N/A N/A | Aura Biosciences Inc. | AURA | Medicxi Ventures Management (Jersey) Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi Growth I GP Ltd 10% Owner | 4,659,784 | $0 | 70,540 (Indirect) | View |
| 2021-11-02 Conversion | 2021-11-04 4:44 pm | N/A N/A | Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 2,327,870 | $0 | 4,112,870 (Indirect) | View |